Europe Hereditary Genetic Testing Market Research 2024-2033, Competitive Analysis of Centogene, Eurofins Scientific, and F. Hoffmann-La Roche - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Hereditary Genetic Testing Market: Focus on Genetic Testing Type and Country - Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.

The Europe hereditary genetic testing market was valued at $7.13 billion in 2024 and is anticipated to reach $21.06 billion by 2034, witnessing a CAGR of 12.79% during the forecast period 2024-2033.

The market for hereditary genetic testing in Europe is growing quickly due to developments in genetic sequencing technologies, rising awareness, and a growing need for individualized medical care. In order to diagnose inherited disorders, detect genetic disease predispositions, and facilitate early interventions for conditions like rare genetic disorders, cystic fibrosis, and hereditary cancers, hereditary genetic testing is essential.

The accuracy, effectiveness, and affordability of genetic tests have increased dramatically with the widespread use of next-generation sequencing (NGS) technologies, opening up access to them for patients and healthcare professionals alike. Further propelling market expansion are government initiatives supporting newborn screening and carrier testing programs, as well as advantageous regulatory frameworks and reimbursement policies.

The rising incidence of genetic disorders and hereditary cancers is driving demand for comprehensive testing solutions. Additionally growing in popularity are direct-to-consumer (DTC) genetic testing services, which give people access to genetic information without a doctor's prescription. The market's scope is being further expanded by significant investments in reproductive health testing, oncology genetics, and personalized medicine.

The market for hereditary genetic testing is expected to grow steadily as long as Europe prioritizes precision medicine and early disease detection. This growth will be aided by technological advancements, harmonized regulations, and rising public awareness.

How can this report add value to an organization?

Product/Innovation Strategy: The Europe hereditary genetic testing market has been extensively segmented based on various categories, such as genetic testing type and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, and collaborations accounted for the maximum number of key developments.

Competitive Strategy: The Europe hereditary genetic testing market has numerous established players with product portfolios. Key players in the Europe hereditary genetic testing market analyzed and profiled in the study involve established players offering products for hereditary genetic testing.

Key Market Players and Competition Synopsis

• Centogene AG
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd

Key Attributes:

Report Attribute	Details
No. of Pages	60
Forecast Period	2024 - 2033
Estimated Market Value (USD) in 2024	$7.13 Billion
Forecasted Market Value (USD) by 2033	$21.06 Billion
Compound Annual Growth Rate	12.7%
Regions Covered	Europe

Key Topics Covered:

Executive Summary

Scope and Definition

1 Hereditary Genetic Testing: Industry Outlook

1.1 Current State of Hereditary Genetic Testing

1.2 Market Footprint and Future Potential

1.3 Trends: Current and Future Impact Assessment

1.3.1 Increasing Demand for Direct-to-consumer Testing

1.3.2 Increasing Launch of Innovative Products and Regulatory Approvals in Genetic Testing Ecosystem

1.4 R&D Review

1.4.1 Patent Filing Trend (by Year, Country)

1.5 Total Addressable Market and Penetration

1.6 Legal and Regulatory Framework

1.6.1 Europe

1.6.1.1 Germany

1.6.1.2 France

1.6.1.3 Italy

1.7 Reimbursement Scenario

1.8 Market Dynamics

1.8.1 Market Drivers

1.8.1.1 Rising Prevalence of Genetic Disorders along with Rare Diseases

1.8.1.2 Increasing Inorganic Growth Activities in the Field of Hereditary Genetic Testing

1.8.1.3 Increasing Number of Hereditary Genetic Tests

1.8.2 Market Restraints

1.8.2.1 High Cost Associated with Testing

1.8.2.2 Shortage of Genetic Counselors

1.8.3 Market Opportunities

1.8.3.1 Expansion into Emerging Markets

2 Region

2.1 Drivers and Restraints

2.2 Europe

2.2.1 Regional Overview

2.2.2 Driving Factors for Market Growth

2.2.3 Factors Challenging the Market

2.2.4 France

2.2.5 Germany

2.2.6 U.K.

2.2.7 Spain

2.2.8 Netherlands

2.2.9 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

3.1 Competitive Landscape

3.1.1 Key Strategies and Development

3.1.1.1 Mergers and Acquisitions

3.1.1.2 Product Launches

3.1.1.3 Synergistic Activities

3.1.1.4 Business Expansion Activities and Others

3.1.2 Company Share Analysis

3.2 Company Profiles

3.2.1 Centogene AG

3.2.1.1 Overview

3.2.1.2 Top Products/Product Portfolio

3.2.1.3 Top Competitors

3.2.1.4 Key Personnel

3.2.1.5 Analyst View

3.2.2 Eurofins Scientific SE

3.2.2.1 Overview

3.2.2.2 Top Products

3.2.2.3 Top Competitors

3.2.2.4 Key Personnel

3.2.2.5 Analyst View

3.2.3 F. Hoffmann-La Roche Ltd

3.2.3.1 Top Products

3.2.3.2 Top Competitors

3.2.3.3 Key Personnel

3.2.3.4 Analyst View

4 Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/kohfuj

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.